-
My Account
In App
My Account
Not Rated
|
Fund Size
(0.37% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 07-Nov-25 | 10134.00 | 1.34% | - | 1.06% | 75/230 |
| 1 Month | 14-Oct-25 | 10249.40 | 2.49% | - | 2.14% | 85/226 |
| 3 Month | 14-Aug-25 | 10158.00 | 1.58% | - | 4.73% | 199/224 |
| 6 Month | 14-May-25 | 11008.40 | 10.08% | - | 8.05% | 44/214 |
| YTD | 01-Jan-25 | 10374.00 | 3.74% | - | 5.51% | 108/201 |
| 1 Year | 14-Nov-24 | 11194.00 | 11.94% | 11.94% | 8.71% | 51/187 |
| 2 Year | 13-Nov-23 | 17337.00 | 73.37% | 31.57% | 20.48% | 4/141 |
| Since Inception | 04-Oct-23 | 18064.20 | 80.64% | 32.26% | 14.34% | 3/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12957.54 | 7.98 % | 15.07 % |
| 2 Year | 13-Nov-23 | 24000 | 29713.31 | 23.81 % | 21.96 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 2104.3 | 10.70% | 0.23% | 13.48% (Nov 2024) | 10.39% (Aug 2025) | 12.45 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 1745.5 | 8.87% | 1.11% | 10.24% (May 2025) | 7.18% (Dec 2024) | 2.59 L | 556.00 |
| Lupin Ltd. | Pharmaceuticals | 1311.2 | 6.67% | -0.17% | 6.84% (Sep 2025) | 5.35% (Jan 2025) | 6.68 L | -0.11 L |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1189.3 | 6.05% | -0.88% | 7.42% (Jul 2025) | 2.99% (Feb 2025) | 6.29 L | -0.44 L |
| Alkem Laboratories Ltd. | Pharmaceuticals | 1147 | 5.83% | -0.11% | 5.94% (Sep 2025) | 0% (Nov 2024) | 2.08 L | 773.00 |
| Max Healthcare Institute Ltd. | Hospital | 1078.9 | 5.49% | 0.83% | 5.49% (Oct 2025) | 2.03% (Nov 2024) | 9.40 L | 1.48 L |
| Ipca Laboratories Ltd. | Pharmaceuticals | 810.1 | 4.12% | -0.38% | 4.62% (Aug 2025) | 3.26% (Jan 2025) | 6.37 L | 0.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 747 | 3.80% | 0.22% | 3.8% (Oct 2025) | 0% (Nov 2024) | 7.83 L | -0.23 L |
| Aster DM Healthcare Ltd. | Hospital | 728.9 | 3.71% | 0.16% | 3.92% (May 2025) | 3.28% (Feb 2025) | 10.75 L | 0.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 714.2 | 3.63% | -0.18% | 3.88% (Jul 2025) | 2.57% (Nov 2024) | 2.01 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.91% |
| Net Receivables | Net Receivables | -0.22% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 2.75 | 14.90 | 45.71 | 45.35 | 37.04 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 0.99 | 2.73 | 14.92 | 29.78 | 15.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.59 | 10.15 | 19.63 | 27.32 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 1.74 | 8.55 | 17.85 | 24.60 | 13.66 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | -0.66 | 10.43 | 19.32 | 24.58 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 3.84 | 9.67 | 9.60 | 24.09 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.03 | 7.61 | 12.01 | 23.52 | 21.10 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 1.60 | 8.54 | 8.13 | 23.39 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.54 | 6.08 | 5.62 | 23.22 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.30 | 3.80 | 13.49 | 23.18 | 17.98 |
Out of 86 mutual fund schemes offered by this AMC, 5 is/are ranked 5 * , 6 is/are ranked 4 * , 11 is/are ranked 3 * , 6 is/are ranked 2 * , 1 is/are ranked 1 * , and 57 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| HDFC Balanced Advantage Fund - Direct Plan - Growth | 4 | 106493.55 | 2.37 | 4.28 | 5.39 | 9.12 | 19.08 |
| HDFC Flexi Cap Fund - Direct Plan - Growth | 5 | 91041.00 | 1.43 | 5.02 | 7.12 | 12.89 | 22.36 |
| HDFC Mid Cap Fund - Direct Plan - Growth | 4 | 89383.23 | 3.84 | 6.52 | 10.73 | 12.50 | 27.00 |
| HDFC Liquid Fund - Direct Plan - Growth | 3 | 61646.54 | 0.49 | 1.45 | 3.01 | 6.72 | 7.05 |
| HDFC Large Cap Fund - Direct Plan - Growth | 3 | 39779.26 | 2.53 | 4.42 | 5.18 | 8.20 | 16.36 |
| HDFC Small Cap Fund - Direct Plan - Growth | 4 | 38412.10 | 1.53 | 2.92 | 10.48 | 7.08 | 23.21 |
| HDFC Money Market Fund - Direct Plan - Growth | 3 | 36903.78 | 0.50 | 1.51 | 3.36 | 7.70 | 7.67 |
| HDFC Corporate Bond Fund - Direct Plan - Growth | 2 | 36133.95 | 0.41 | 1.60 | 2.78 | 8.11 | 8.12 |
| HDFC Large and Mid Cap Fund - Direct Plan - Growth | 4 | 28486.64 | 2.45 | 5.20 | 7.81 | 10.00 | 21.22 |
| HDFC Low Duration Fund - Direct Plan - Growth | 2 | 25493.10 | 0.57 | 1.65 | 3.54 | 7.95 | 7.90 |
